Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction

This secondary analysis of the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure (FINEARTS-HF) randomized clinical trial evaluates the effect of finerenone on outpatient worsening heart failure events requiring oral diuretic intensification among patients with heart failure with mildly reduced or preserved ejection fraction.